Aberdeen Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$509K Sell
6,508
-5,346
-45% -$431K 0.24% 66
2026
Q1
$1.03M Hold
11,854
0.47% 43
2025
Q4
$1.14M Sell
11,854
-125
-1% -$12.1K 0.53% 37
2025
Q3
$1.14M Sell
11,979
-700
-6% -$64.3K 0.72% 31
2025
Q2
$1.11M Hold
12,679
0.73% 32
2025
Q1
$1.14M Sell
12,679
-200
-2% -$17.9K 0.79% 34
2024
Q4
$1.03M Sell
12,879
-250
-2% -$21.6K 0.7% 35
2024
Q3
$1.18M Sell
13,129
-1,151
-8% -$96.8K 0.78% 35
2024
Q2
$1.12M Buy
14,280
+701
+5% +$57.5K 0.76% 37
2024
Q1
$1.18M Hold
13,579
0.69% 36
2023
Q4
$1.12M Hold
13,579
0.81% 34
2023
Q3
$1.06M Hold
13,579
0.8% 34
2023
Q2
$1.2M Hold
13,579
0.86% 32
2023
Q1
$1.09M Hold
13,579
0.82% 35
2022
Q4
$1.06M Hold
13,579
0.8% 38
2022
Q3
$1.1M Hold
13,579
0.97% 29
2022
Q2
$1.22M Hold
13,579
0.97% 29
2022
Q1
$1.51M Buy
13,579
+421
+3% +$44.5K 1.03% 24
2021
Q4
$1.36M Buy
13,158
+134
+1% +$15.5K 0.89% 28
2021
Q3
$1.63M Sell
13,024
-200
-2% -$25.9K 1.58% 16
2021
Q2
$1.64M Hold
13,224
1.51% 17
2021
Q1
$1.56M Sell
13,224
-133
-1% -$15.6K 1.24% 23
2020
Q4
$1.56M Buy
13,357
+45
+0.3% +$4.95K 1.18% 24
2020
Q3
$1.38M Sell
13,312
-907
-6% -$91.1K 1.32% 21
2020
Q2
$1.3M Buy
14,219
+707
+5% +$67.8K 1.4% 19
2020
Q1
$1.22M Hold
13,512
1.48% 17
2019
Q4
$1.53M Buy
+13,512
New +$1.48M 1.14% 15

Other funds holding MDT

Aberdeen Wealth Management's MDT Position: Q2 2026 in Review

Aberdeen Wealth Management reduced its Medtronic (MDT) stake by 45% in Q2 2026, selling an estimated $431K and leaving 6,508 shares worth $509K. The position accounts for 0.24% of the portfolio, ranked #66.

Aberdeen Wealth Management first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.64M in Q2 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Aberdeen Wealth Management held 6,508 shares of Medtronic worth $509K as of Q2 2026.
  • Aberdeen Wealth Management sold 5,346 Medtronic shares in Q2 2026, an estimated $431K.
  • Medtronic made up 0.24% of Aberdeen Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Aberdeen Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • Aberdeen Wealth Management's Medtronic position peaked at $1.64M in Q2 2021.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.